Related Experiment Video
Updated: Feb 14, 2026

Development of Human Renal Tubular Epithelial Cell Primary Cultures in Monolayers and Three-Dimensional Conditions
Published on: June 13, 2025
Type IV renal tubular acidosis and spironolactone therapy in the elderly
1Geriatric Medicine Unit, University of Edinburgh, City Hospital, UK.
Abstract:
Spironolactone therapy is a well-known cause of hyperkalaemia, but in susceptible patient, it may also be associated with metabolic acidosis. We report a case of severe renal tubular acidosis (Type IV) with life-threatening hyperkalaemia caused by spironolactone, and discuss the mechanisms by which this may occur.
Related Concept Videos
Continuous Renal Replacement Therapy
Renal Drug Excretion: Tubular Reabsorption
Renal Drug Excretion: Tubular Secretion
Drug Elimination by Renal Route: Tubular Secretion
Drug Elimination by Renal Route: Tubular Reabsorption
Type IV Collagen of Basal Lamina
A type IV collagen molecule has six alpha chains which can...

